ResMed Partners EDB to Expand Singapore Operations
ResMed Partners EDB to Expand Singapore Operations
The company will increase its production capacity and advance its technology in Singapore.
公司将在新加坡增加生产能力并提升其科技。
ResMed has partnered with the Singapore Economic Development Board (EDB) to expand its operations in Singapore.
瑞思迈已与新加坡经济发展局(EDB)合作,扩大了在新加坡的业务。
As part of its new investments in Singapore in 2029, ResMed will boost its production capacity, drive advanced manufacturing process innovation, and support the growth of its Digital Science and Artificial Intelligence (AI) Lab (DSAIL).
作为其在2029年新加坡的新投资的一部分,瑞思迈将增加其生产能力,推动先进的制造业-半导体技术创新,并支持其数字科技和人工智能实验室(DSAIL)的增长。
These investments and partnerships will boost ResMed's advancements in sleep health, breathing health, and home health technology.
"We have been in Singapore for over two decades, and this EDB partnership reflects our ongoing commitment to leveraging Singapore's exceptional digital infrastructure, talent, and technology to help us achieve our goal of improving the lives of 500 million people by 2030," Mick Farrell, CEO of ResMed said.
这些投资和合作将推动瑞思迈在睡眠健康、呼吸健康和家庭健康科技方面的进步。
“我们在新加坡已有20多年的时间,这种与EDb的合作反映了我们对利用新加坡出色的数字基础设施、人才和科技的持续承诺,帮助我们实现到2030年改善50000万人生活的目标,”瑞思迈的CEO Mick Farrell说。
ResMed currently provides 1,300 jobs in Singapore.
瑞思迈目前在新加坡提供1300个工作岗位。